文献速递产科母胎医学

他汀类药物用于子痫前期或胎儿生长受限:跨物种系统评价与荟萃分析对母体血压和胎儿生长的影响

Statins in pre-eclampsia or fetal growth restriction: A systematic review and meta-analysis on maternal blood pressure and fetal growth across species.
PubMed 文献 · BJOG · 2023-02-20

该系统评价与荟萃分析纳入1项人类研究和12项动物研究,评估他汀对子痫前期或胎儿生长受限妊娠的母体血压和出生体重的影响。结果显示产前使用他汀显著降低母体血压(SMD -2.49 mmHg,95%CI -4.26至-0.71,p=0.01),但对出生体重无显著影响(SMD 0.69,95%CI -0.65至2.03,p=0.28)。作者认为置信区间宽、效应方向不一致且偏倚风险大,缺乏进一步人类随机对照试验的坚实基础。

要点

  • 产前使用他汀显著降低子痫前期或胎儿生长受限妊娠的母体血压(SMD -2.49 mmHg)。
  • 他汀对出生体重无显著影响(SMD 0.69,95%CI -0.65至2.03)。
  • 亚组分析显示不同剂量、物种或给药途径对母体血压无影响。

核心结论

  • 跨物种荟萃分析表明,他汀仅降低子痫前期或胎儿生长受限的啮齿类动物妊娠的母体血压,对出生体重无跨物种影响。
  • 置信区间宽、研究间效应方向不一致且偏倚风险大,作者认为缺乏进一步人类随机对照试验的坚实基础。

研究设计与样本

  • 系统评价与荟萃分析,纳入随机对照试验、有匹配对照组的队列研究以及动物研究。
  • 共纳入1项人类研究和12项动物研究。
  • 检索PubMed和Embase.com,检索日期为2022年5月10日,使用「他汀」和「妊娠」作为检索词。
  • 主要结局为母体血压(mmHg)和出生体重(克),计算标准化均数差(SMD)及95%置信区间(CI)。
  • 若亚组至少包含3项研究,则按物种、他汀种类、剂量、给药时机和给药途径进行亚组分析。

主要发现

  • 产前使用他汀显著降低妊娠期母体血压(SMD -2.49 mmHg,95%CI -4.26至-0.71,p=0.01)。
  • 他汀对出生体重无显著影响(SMD 0.69,95%CI -0.65至2.03,p=0.28)。
  • 亚组分析显示不同剂量、物种或给药途径对母体血压无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 置信区间宽。
  • 研究间观察到的效应方向不一致。
  • 偏倚风险大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several human randomised controlled trials (RCTs) are investigating the effects of statins on pre-eclampsia (PE) and fetal growth restriction (FGR). This cross-species meta-analysis summarises the preclinical evidence of statin use for PE and FGR. OBJECTIVES: Evaluate the effects of statins on maternal blood pressure (MBP) and birthweight (BW) in pregnancies complicated by PE or FGR. SEARCH STRATEGY: PubMed and Embase.com were searched on 10 May 2022 using 'statins' and 'pregnancy'. SELECTION CRITERIA: We included RCTs and cohorts with matched control groups as well as animal studies. DATA COLLECTION AND ANALYSIS: The main outcomes were MBP in mmHg and BW in grams. The standardised mean difference (SMD) with a 95% confidence interval (CI) was calculated. Subgroup analyses on species, statin, dose, timing and route of administration were performed if subgroups included at least three studies. MAIN RESULTS: Our data included one human and 12 animal studies. Prenatal administration of statins significantly reduced MBP during pregnancy (SMD -2.49 mmHg [95% CI -4.26 to -0.71], p = 0.01). There was no significant effect of statins on BW (SMD 0.69 [95% CI -0.65 to 2.03], p = 0.28). Our subgroup analyses showed no effect on MBP of different doses, species or route of administration. CONCLUSIONS: Our cross-species meta-analyses demonstrate that statins only reduce maternal blood pressure in rodent pregnancies complicated by pre-eclampsia or fetal growth restriction and have no effect on birthweight across species. The broad confidence intervals, inconsistent direction of the observed effects across the studies and large risk of bias lead us to conclude that a solid base for further human RCTs is lacking.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Meijerink L, Wever KE, Terstappen F, et al. Statins in pre-eclampsia or fetal growth restriction: A systematic review and meta-analysis on maternal blood pressure and fetal growth across species. BJOG. 2023. PMID: 36681887. doi:10.1111/1471-0528.17393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。